<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Scientific &amp; Technical Instruments</title>
	<atom:link href="http://www.stockbloghub.com/category/scientific-technical-instruments/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 16 May 2012 17:53:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(GRMN) Garmin Expands Overseas</title>
		<link>http://www.stockbloghub.com/2012/04/26/grmn-garmin-expands-overseas/99484</link>
		<comments>http://www.stockbloghub.com/2012/04/26/grmn-garmin-expands-overseas/99484#comments</comments>
		<pubDate>Thu, 26 Apr 2012 18:06:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Garmin Limited]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[GRMN]]></category>
		<category><![CDATA[Research In Motion Limited]]></category>
		<category><![CDATA[RIMM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=99484</guid>
		<description><![CDATA[Garmin Ltd (GRMN), the maker of portable navigation devices, has opened offices in Shanghai, China; Stuttgart, Germany; and Yokohama, Japan. The idea is to get closer to all the major auto manufacturing markets of the world to sell built-in devices for automobiles including navigation, telematics and infotainment. Garmin has been the most celebrated supplier of personal navigation devices (PND) that were largely used in automobiles. However, the incorporation of navigation into smartphones started to eat away its core market. Garmin tried to enter the smartphone market itself, but given the stiff competition from stalwarts like Apple (AAPL), Google (GOOG) through devices from LG, HTC and Samsung, and Research In Motion (RIMM), Garmin could not create a niche for itself. Others in the space were increasingly selling navigation as software for ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/26/grmn-garmin-expands-overseas/99484/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GRMN) Garmin Limited Quarterly Earnings Blew Past Estimates</title>
		<link>http://www.stockbloghub.com/2012/02/23/grmn-garmin-limited-quarterly-earnings-blew-past-estimates/92296</link>
		<comments>http://www.stockbloghub.com/2012/02/23/grmn-garmin-limited-quarterly-earnings-blew-past-estimates/92296#comments</comments>
		<pubDate>Thu, 23 Feb 2012 19:32:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Garmin Limited]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[GRMN]]></category>
		<category><![CDATA[Research In Motion Limited]]></category>
		<category><![CDATA[RIMM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=92296</guid>
		<description><![CDATA[Garmin Ltd. (GRMN) reported quarter earnings that beat the Zacks Consensus Estimates by 20 cents, or 30.5%. Currency had an 11 cent negative impact on earnings, and if excluded would have raised the EPS by a like amount. Revenue exceeded the consensus by 18.1%. Garmin is deferring lifetime maps, connected services and premium traffic over their economic lives. Net deferrals were 26 cents a share in the last quarter. Revenue Garmin’s fourth-quarter revenue of $909.6 million was up 36.4% sequentially and 8.6% year over year, helped by positive seasonality that pushed up sales of both personal navigation devices (PNDs) and outdoor/fitness products. Volumes were up 75.2%, just past the levels in the year-ago quarter. However, the blended average selling price (“ASP”) dropped 22.2% sequentially while increasing 7.7% from last year, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/02/23/grmn-garmin-limited-quarterly-earnings-blew-past-estimates/92296/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TMO) Thermo Fisher Scientific Shares Maintained at Neutral</title>
		<link>http://www.stockbloghub.com/2011/11/30/tmo-thermo-fisher-scientific-shares-maintained-at-neutral/87822</link>
		<comments>http://www.stockbloghub.com/2011/11/30/tmo-thermo-fisher-scientific-shares-maintained-at-neutral/87822#comments</comments>
		<pubDate>Wed, 30 Nov 2011 20:05:19 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Illumina Inc]]></category>
		<category><![CDATA[ILMN]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87822</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Thermo Fisher Scientific (TMO) with a target price of $47.00. Thermo Fisher continues to be focused on effectively deploying its cash balance to create value through share buybacks and suitable acquisitions. Significant acquisitions include that of Dionex Corporation and Phadia. The former brings in ion and liquid chromatography portfolio while the latter is a leading player in allergy and autoimmunity diagnostics. Thermo Fisher is actively focused on improving its operating margin. The initiatives include adoption of Practical Process Improvement (PPI) and PPI-Lean projects, continued tight cost control on discretionary spending and infrastructure optimization that includes reduced footprint and expanded low-cost region (LCR) manufacturing (China, Mexico and Eastern Europe). Of Thermo Fisher’s four end markets – Industrial/Applied, Biopharma, Healthcare and Government/Academic – the company ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/30/tmo-thermo-fisher-scientific-shares-maintained-at-neutral/87822/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GRMN) Garmin Limited &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2011/11/22/grmn-garmin-limited-bull-of-the-day/87378</link>
		<comments>http://www.stockbloghub.com/2011/11/22/grmn-garmin-limited-bull-of-the-day/87378#comments</comments>
		<pubDate>Tue, 22 Nov 2011 17:33:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Garmin Limited]]></category>
		<category><![CDATA[GRMN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87378</guid>
		<description><![CDATA[Garmin Ltd. (GRMN) is an OEM of GPS-based equipment. September quarter earnings thrashed the Zacks Consensus Estimate and 2011 guidance was raised. Garmin s market share, brand equity, compelling new products across segments, significant diversification of revenue, strategic alliances and financial position may be expected to offset the negative impact of a secular decline in its core PND business. We are buyers of the shares at the current valuation, since we believe that Garmin has the position and financial muscle to overcome the fierce competition, pricing pressure and PND cannibalization by smartphones. Garmin&#8217;s current trailing 12-month earnings multiple is 14.0X, compared to the 16.2X average for the peer group and 17.0X for the S&#38;P 500. We note that Garmin&#8217;s expected earnings growth rate of 15.0% over the next 5 years ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/22/grmn-garmin-limited-bull-of-the-day/87378/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AFFX) Affymetrix&#8217;s Second Quarter Preliminary Sales Miss</title>
		<link>http://www.stockbloghub.com/2011/07/11/affx-affymetrixs-second-quarter-preliminary-sales-miss/78586</link>
		<comments>http://www.stockbloghub.com/2011/07/11/affx-affymetrixs-second-quarter-preliminary-sales-miss/78586#comments</comments>
		<pubDate>Mon, 11 Jul 2011 16:02:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AFFX]]></category>
		<category><![CDATA[Affymetrix Inc]]></category>
		<category><![CDATA[Illumina Inc]]></category>
		<category><![CDATA[ILMN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78586</guid>
		<description><![CDATA[Genetic products maker Affymetrix Inc (AFFX) has announced disappointing preliminary sales for second-quarter fiscal 2011. The California-based company expects to post revenues in the band of $64-65 million for the quarter, which is below the current Street view of roughly $74 million. Affymetrix’s shares tanked $1.55 (or 19.4%) to $6.45 in after-hours trading on July 6. The company is expected to report final results for the second quarter after the closing gong on July 27. Affymetrix expects product sales for the quarter in the range of roughly $58-59 million, including consumable and instrument sales of approximately $55 million and $3.5 million, respectively. Service revenues are expected to be roughly $5 million while license and royalty revenues are expected inthe vicinity of $1 million. The company noted that its second quarter ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/11/affx-affymetrixs-second-quarter-preliminary-sales-miss/78586/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ITRI) Itron Installs ChoiceConnect</title>
		<link>http://www.stockbloghub.com/2011/07/10/itri-itron-installs-choiceconnect/78582</link>
		<comments>http://www.stockbloghub.com/2011/07/10/itri-itron-installs-choiceconnect/78582#comments</comments>
		<pubDate>Sun, 10 Jul 2011 18:17:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AVA]]></category>
		<category><![CDATA[Avista Corporation]]></category>
		<category><![CDATA[Centerpoint Energy Inc.]]></category>
		<category><![CDATA[CNP]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[ITRI]]></category>
		<category><![CDATA[Itron Inc]]></category>
		<category><![CDATA[ROP]]></category>
		<category><![CDATA[Roper Industries Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78582</guid>
		<description><![CDATA[Itron Inc. (ITRI) recently announced the completion of the installation of more than 150,000 Itron gas meter communication modules in Greater Houston for a natural gas distribution subsidiary of CenterPoint Energy Inc. (CNP). The project will include a total of 1.2 million communication modules and will be completed by 2013. These meters can effectively do away with the necessity of entering the premises of customers to take the readings manually. These communication modules employ the radio transmitting devices attached to the CenterPoint Energy’s customers’ existing natural gas meters, enabling the collection of readings once a month by a mobile meter reading device mounted to a CenterPoint Energy vehicle. According to Itron, CenterPoint is an old and valued customer and Itron is looking forward to conferring the benefits of smart metering ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/10/itri-itron-installs-choiceconnect/78582/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ITRI) Itron &amp; Tropos Networks&#8217; Smart Grid Chosen by Avista Corporation</title>
		<link>http://www.stockbloghub.com/2011/06/29/itri-itron-tropos-networks-smart-grid-chosen-by-avista-corporation/77901</link>
		<comments>http://www.stockbloghub.com/2011/06/29/itri-itron-tropos-networks-smart-grid-chosen-by-avista-corporation/77901#comments</comments>
		<pubDate>Wed, 29 Jun 2011 20:56:34 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AVA]]></category>
		<category><![CDATA[Avista Corporation]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[ITRI]]></category>
		<category><![CDATA[Itron Inc]]></category>
		<category><![CDATA[ROP]]></category>
		<category><![CDATA[Roper Industries Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77901</guid>
		<description><![CDATA[Itron Inc. (ITRI) and Tropos Networks’ jointly developed Smart Grid solution has been chosen by Avista Corp. (AVA) as part of its $38 million Smart Grid Demonstration Project in the city of Pullman, Washington, and in a nearby locality of Albion. The sole objective of using automated smart technologies is to simplify the energy distribution system and increase the accountability, reliability and efficiency of the system. Besides, the system will also reduce the outage time, incorporate renewable energy sources, and offer customers solutions to monitor their energy usage. Itron’s OpenWay Integrated Cell Router and OpenWay 7320 wireless broadband router will be used for smart grid communications. Both incorporate Tropos’ GridCom, a wireless broadband technology. The network will connect smart meters and distribution automation devices, laying the foundation of cost-effective, reliable ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/29/itri-itron-tropos-networks-smart-grid-chosen-by-avista-corporation/77901/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CPHD) Cepheid Targets Infectious Diseases</title>
		<link>http://www.stockbloghub.com/2011/06/28/cphd-cepheid-targets-infectious-diseases/77663</link>
		<comments>http://www.stockbloghub.com/2011/06/28/cphd-cepheid-targets-infectious-diseases/77663#comments</comments>
		<pubDate>Tue, 28 Jun 2011 16:00:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Cepheid]]></category>
		<category><![CDATA[CPHD]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77663</guid>
		<description><![CDATA[Cepheid (CPHD) announced the appointment of Robert Kwiatkowski as the Vice President of Infectious Disease Research and Development. He would be reporting to David Persing, the company’s Chief Medical and Technology Officer. Dr. Kwiatkowski walks into Cepheid with extensive experience in nucleic acid infectious disease test development and management, including tests for HPV, HIV and HCV. Before this appointment, Dr. Kwiatkowski was responsible for managing infectious disease test development to support multiple automated platforms at Siemens Healthcare Diagnostics. Cepheidhas a broad portfolio of tests that runs on its GeneXpert system. Although the company is one of the leading players in the Healthcare Associated Infections (HAI) segment, it is also looking at expanding in non-HAI markets which includes critical infectious diseases, women’s health, and oncology and genetics. Additional tests under development ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/28/cphd-cepheid-targets-infectious-diseases/77663/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GRMN) Garmin Acquires Navigon</title>
		<link>http://www.stockbloghub.com/2011/06/20/grmn-garmin-acquires-navigon/76859</link>
		<comments>http://www.stockbloghub.com/2011/06/20/grmn-garmin-acquires-navigon/76859#comments</comments>
		<pubDate>Tue, 21 Jun 2011 04:16:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Garmin Limited]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[GRMN]]></category>
		<category><![CDATA[Hewlett-Packard Company]]></category>
		<category><![CDATA[HPQ]]></category>
		<category><![CDATA[NOK]]></category>
		<category><![CDATA[Nokia Corporation]]></category>
		<category><![CDATA[Research In Motion Limited]]></category>
		<category><![CDATA[RIMM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76859</guid>
		<description><![CDATA[Garmin Ltd (GRMN), one of the leading providers of navigation devices into the outdoor/fitness, aviation, marine and automotive markets recently beefed up its business in Europe. Garmin announced the acquisition of European navigation device provider Navigon AG, 90% of which is owned by private equity firm General Atlantic Partners. Although Garmin did not announce the price, a German daily reported in early June that Garmin offered 50 million euros ($72.14 million) for the company. Navigon brings several advantages to Garmin. The most obvious of these is its relationships with mobile phone, automotive and consumer electronics OEMs. Garmin could leverage on these relationships to grow its position in Europe. Navigon has very popular mobile apps for Apple Inc’s (AAPL) iPhone and Google Inc’s (GOOG) Android-based phones in both Europe and North ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/20/grmn-garmin-acquires-navigon/76859/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AFFX) Company News for June 03, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/06/03/affx-company-news-for-june-03-2011-corporate-summary/75495</link>
		<comments>http://www.stockbloghub.com/2011/06/03/affx-company-news-for-june-03-2011-corporate-summary/75495#comments</comments>
		<pubDate>Sat, 04 Jun 2011 05:03:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AFFX]]></category>
		<category><![CDATA[Affymetrix Inc]]></category>
		<category><![CDATA[AstraZeneca plc]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DeVry Inc.]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[DV]]></category>
		<category><![CDATA[EnergySolutions Inc]]></category>
		<category><![CDATA[ES]]></category>
		<category><![CDATA[F]]></category>
		<category><![CDATA[Ford Motor Company]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Joy Global Inc.]]></category>
		<category><![CDATA[JOYG]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[Regeneron Pharmaceuticals Inc]]></category>
		<category><![CDATA[REGN]]></category>
		<category><![CDATA[Sempra Energy]]></category>
		<category><![CDATA[SRE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=75495</guid>
		<description><![CDATA[•    Joy Global Inc. (NASDAQ:JOYG) posted Q2 EPS of $1.52, higher than the Zacks Consensus Estimate of $1.35 per share. Revenue for the quarter grew 19% to $1.06 billion, beating the Zacks Consensus Estimate of $1.038 billion •    According to reports, Ford Motor Co (NYSE:F) is planning to invest around $100 million in robotic laser technology which will reduce wind noise inside vehicles •    Baird upgraded shares of Affymetrix, Inc. (NASDAQ:AFFX) to &#8220;Outperform&#8221; rating from &#8220;Neutral&#8221; rating, raising the target price to $11 from $6 •    Shares of Johnson &#38; Johnson (NYSE:JNJ) were upgraded by analysts of First Global to &#8220;Moderate Outperform&#8221; rating from &#8220;Market Perform&#8221; rating •    Analysts at BofA Merrill Lynch upgraded DeVry Inc. (NYSE:DV) to &#8220;Buy&#8221; rating from &#8220;Neutral&#8221; rating with a target price of $68 on ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/03/affx-company-news-for-june-03-2011-corporate-summary/75495/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Company News for May 16, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/05/16/a-company-news-for-may-16-2011-corporate-summary/74126</link>
		<comments>http://www.stockbloghub.com/2011/05/16/a-company-news-for-may-16-2011-corporate-summary/74126#comments</comments>
		<pubDate>Mon, 16 May 2011 17:06:03 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[AIG]]></category>
		<category><![CDATA[American International Group Inc]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[CA]]></category>
		<category><![CDATA[Ca Technologies]]></category>
		<category><![CDATA[Eastman Kodak Company]]></category>
		<category><![CDATA[EK]]></category>
		<category><![CDATA[JWN]]></category>
		<category><![CDATA[Nordstrom Inc.]]></category>
		<category><![CDATA[NVDA]]></category>
		<category><![CDATA[NVIDIA Corporation]]></category>
		<category><![CDATA[SPWRA]]></category>
		<category><![CDATA[Sunpower Corporation]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>
		<category><![CDATA[Yahoo! Inc.]]></category>
		<category><![CDATA[YHOO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74126</guid>
		<description><![CDATA[•    Agilent Technologies&#8217; (NYSE:A) Q2 EPS of $0.74, ex-items, topped the Zacks Consensus Estimates of $0.65 per share •    Nvidia&#8217;s (NASDAQ:NVDA) Q1 EPS of $0.27 topped the Zacks Consensus Estimate of $0.19 per share •    Alibaba Group restructured the ownership of Alipay without informing Yahoo Inc (Nasdaq:YHOO) and Softbank and shares of Yahoo fell subsequently •    CA Technologies (NASDAQ:CA) reported fourth quarter 2011 adjusted earnings per share of $0.46, in line the Zacks Consensus Estimate. Results were driven by growing demand for the company’s products, partially offset by weakness in Europe •    Nordstrom Inc. (NYSE:JWN) posted earnings growth of 32.7% to reach $0.69 per share in the first quarter of fiscal 2011 from $0.52 per share earned in the year-ago period. Earnings per share beat the Zacks Consensus Estimate of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/16/a-company-news-for-may-16-2011-corporate-summary/74126/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BMI) Badger Meter Incorporated &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2011/04/29/bmi-badger-meter-incorporated-bear-of-the-day-2/72780</link>
		<comments>http://www.stockbloghub.com/2011/04/29/bmi-badger-meter-incorporated-bear-of-the-day-2/72780#comments</comments>
		<pubDate>Fri, 29 Apr 2011 13:53:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Badger Meter Inc]]></category>
		<category><![CDATA[BMI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=72780</guid>
		<description><![CDATA[Badger Meter Inc. (BMI) delivered disappointing first quarter results, as EPS declined 39% year over year to $0.22 and fell short of the Zacks Consensus Estimate at $0.43. Net sales dropped 7.2% year over year to $57.4 million, compared to the Zacks Consensus Estimate of $69 million. The increased sales of manual meters were not enough to offset the dismal sale of automatic meters. This resulted in decreased gross margins as manual meters have lower margins compared with the automatic meters. Our long-term Underperform recommendation on the stock indicates that it will perform below the overall market. Our $33 target price, 17.8x our 2011 EPS estimate, reflects this view. BADGER METER (BMI): Free Stock Analysis Report Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/29/bmi-badger-meter-incorporated-bear-of-the-day-2/72780/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BMI) Badger Meter &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2011/04/25/bmi-badger-meter-bear-of-the-day/72291</link>
		<comments>http://www.stockbloghub.com/2011/04/25/bmi-badger-meter-bear-of-the-day/72291#comments</comments>
		<pubDate>Mon, 25 Apr 2011 15:23:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Badger Meter Inc]]></category>
		<category><![CDATA[BMI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=72291</guid>
		<description><![CDATA[Badger Meter (BMI) delivered disappointing first quarter results, as EPS declined 39% year over year to $0.22 and fell short of the Zacks Consensus Estimate at $0.43. Net sales dropped 7.2% year over year to $57.4 million, compared to the Zacks Consensus Estimate of $69 million. The increased sales of manual meters were not enough to offset the dismal sale of automatic meters. This resulted in decreased gross margins as manual meters have lower margins compared with the automatic meters.  However, the long-term prospects of the company seem positive, mainly due to water conservation. We reiterate our Underperform recommendation on the stock with a target price of $33.00. BADGER METER (BMI): Free Stock Analysis Report Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/25/bmi-badger-meter-bear-of-the-day/72291/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AFFX) Affymetrix Analyst Initiates Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/04/17/affx-affymetrix-analyst-initiates-shares-at-neutral/71708</link>
		<comments>http://www.stockbloghub.com/2011/04/17/affx-affymetrix-analyst-initiates-shares-at-neutral/71708#comments</comments>
		<pubDate>Sun, 17 Apr 2011 18:39:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AFFX]]></category>
		<category><![CDATA[Affymetrix Inc]]></category>
		<category><![CDATA[CBMX]]></category>
		<category><![CDATA[CombiMatrix Corporation]]></category>
		<category><![CDATA[Illumina Inc]]></category>
		<category><![CDATA[ILMN]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[Sequenom Inc]]></category>
		<category><![CDATA[SQNM]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71708</guid>
		<description><![CDATA[We initiate our coverage on genetic products maker Affymetrix (AFFX) with a Neutral recommendation. The company posted respectable results in fourth-quarter fiscal 2010 with earnings beating the Zacks Consensus Estimate while profit surged 42% year over year as lower costs more than offset a decline in sales. California-based Affymetrix is a leading provider of microarray-based products and services to the global research community. Along with Illumina Inc. (ILMN), it is one of the two major providers of microarray technologies primarily used in the field of genetic research. Affymetrix has expertise in gene expression monitoring arrays, which are used to identify correlations between genes, determine their biological functions, and identify patterns that enable more accurate disease classification. It has a dominant position in the gene expression market and enjoys a recurring ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/17/affx-affymetrix-analyst-initiates-shares-at-neutral/71708/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AFFX) Affymetrix Intros New Axiom Array</title>
		<link>http://www.stockbloghub.com/2011/04/13/affx-affymetrix-intros-new-axiom-array/71480</link>
		<comments>http://www.stockbloghub.com/2011/04/13/affx-affymetrix-intros-new-axiom-array/71480#comments</comments>
		<pubDate>Thu, 14 Apr 2011 02:30:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AFFX]]></category>
		<category><![CDATA[Affymetrix Inc]]></category>
		<category><![CDATA[Illumina Inc]]></category>
		<category><![CDATA[ILMN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71480</guid>
		<description><![CDATA[Genetic products maker Affymetrix Inc (AFFX) has broadened its Axiom Genotyping Solution (a high-throughput genotyping platform) with the launch of the Axiom Genome-Wide CHB 1 Array. It is the first commercial product designed to maximize genetic coverage of common alleles (an allele is one of a pair or series of genes) in the Han Chinese population. The Genome-Wide CHB 1 Array will offer researchers a powerful and cost-effective tool for studying disease and characterizing the genetic basis of the disease in the Han Chinese population. The Han Chinese are an ethnic group representing roughly 92% of the overall Chinese population. Genome-Wide CHB 1 represents the company’s third population-designed array for the Axiom Genotyping Solution platform. It has the highest coverage of variants in important biological categories compared with other arrays ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/13/affx-affymetrix-intros-new-axiom-array/71480/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ITRI) Itron to Supply Meters to BC Hydro</title>
		<link>http://www.stockbloghub.com/2011/04/12/itri-itron-to-supply-meters-to-bc-hydro/71285</link>
		<comments>http://www.stockbloghub.com/2011/04/12/itri-itron-to-supply-meters-to-bc-hydro/71285#comments</comments>
		<pubDate>Tue, 12 Apr 2011 17:56:08 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Centerpoint Energy Inc.]]></category>
		<category><![CDATA[CNP]]></category>
		<category><![CDATA[DTE]]></category>
		<category><![CDATA[DTE Energy Company]]></category>
		<category><![CDATA[Edison International]]></category>
		<category><![CDATA[EIX]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[ITRI]]></category>
		<category><![CDATA[Itron Inc]]></category>
		<category><![CDATA[ROP]]></category>
		<category><![CDATA[Roper Industries Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71285</guid>
		<description><![CDATA[Itron Inc. (ITRI) has been chosen by British Columbia Hydro (BC Hydro) to supply two million new electric meters over the next two years as part of its Smart Metering Program. With this announcement British Columbia has moved a step closer to modernization. Under the terms of agreement, Itron will provide its OpenWay smart meters, which are run over a multi-application communication network powered by Cisco. Also included in the agreement are associated system software and meter data management system, which provide a cost-effective solution. The value of the contract is approximately worth $270 million. The Smart Metering Program will help in chipping rates from prior levels, leading to savings of about $70 million, for customers, in the first three years of implementation. Net benefits accrued from the program would ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/12/itri-itron-to-supply-meters-to-bc-hydro/71285/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Agilent Technologies &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2011/04/07/a-agilent-technologies-bull-of-the-day-2/70877</link>
		<comments>http://www.stockbloghub.com/2011/04/07/a-agilent-technologies-bull-of-the-day-2/70877#comments</comments>
		<pubDate>Thu, 07 Apr 2011 14:05:01 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70877</guid>
		<description><![CDATA[Agilent Technologies (A) is a broad-based OEM of test and measurement equipment. The company&#8217;s January quarter earnings beat the Zacks Consensus Estimate, helped by revenue growth, operating margin expansion and a lower tax rate. Agilent&#8217;s leadership position, history of innovation, stable gross margins and steadily improving operating margins, turnaround in the EM segment, acquisition strategy and position in China are the chief elements of our positive thesis. In contrast, the stabilization in the EM segment, impact of Varian and high debt position are not that much of a concern. We believe Agilent shares are undervalued at these levels. We are therefore reiterating our Outperform recommendation and raising the price target to $54.00 (20.5X 2011 EPS). AGILENT TECH (A): Free Stock Analysis Report Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/07/a-agilent-technologies-bull-of-the-day-2/70877/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Stock Market News for March 7, 2011 &#8211; Market News</title>
		<link>http://www.stockbloghub.com/2011/03/07/a-stock-market-news-for-march-7-2011-market-news/68182</link>
		<comments>http://www.stockbloghub.com/2011/03/07/a-stock-market-news-for-march-7-2011-market-news/68182#comments</comments>
		<pubDate>Tue, 08 Mar 2011 06:02:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[EXPE]]></category>
		<category><![CDATA[Expedia Inc.]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Hewlett-Packard Company]]></category>
		<category><![CDATA[HPQ]]></category>
		<category><![CDATA[JDS Uniphase Corporation]]></category>
		<category><![CDATA[JDSU]]></category>
		<category><![CDATA[KB Home]]></category>
		<category><![CDATA[KBH]]></category>
		<category><![CDATA[Marvell Technology Group Limited]]></category>
		<category><![CDATA[MRVL]]></category>
		<category><![CDATA[Netflix Inc.]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[RYL]]></category>
		<category><![CDATA[Ryland Group Inc.]]></category>
		<category><![CDATA[Weyerhaeuser Company]]></category>
		<category><![CDATA[WY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=68182</guid>
		<description><![CDATA[Crude prices soared to more than $104 per barrel, the highest level since September 2008, following continued tension in Libya and dragged the markets lower on Friday. Not only did surging crude prices erase most of the gains for the week, it also negated the positive sentiment coming from the decline in unemployment rate. The fear gauge CBOE Volatility Index (VIX) jumped 2.7% to 19.11. The Dow Jones Industrial Average (DJIA) dropped 0.7% to close at 12,169.88. The Standard &#38; Poor 500 (S&#38;P 500) was down 0.7% and finished the day at 1,321.15. The Nasdaq Composite Index ended at 2,784.67 and shed 0.5%. On the New York Stock Exchange, NYSE Amex and Nasdaq, consolidated volumes were at 7.73 billion shares and below last year&#8217;s daily average of 8.47 billion. Weekly ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/07/a-stock-market-news-for-march-7-2011-market-news/68182/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GRMN) Garmin Quarterly Earnings Misses Consensus</title>
		<link>http://www.stockbloghub.com/2011/02/26/grmn-garmin-quarterly-earnings-misses-consensus/67575</link>
		<comments>http://www.stockbloghub.com/2011/02/26/grmn-garmin-quarterly-earnings-misses-consensus/67575#comments</comments>
		<pubDate>Sat, 26 Feb 2011 22:26:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Garmin Limited]]></category>
		<category><![CDATA[GRMN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67575</guid>
		<description><![CDATA[Garmin Ltd. (GRMN) reported fourth quarter earnings that missed consensus estimates by 19 cents, or 21.8%. Currency had a 15 cent negative impact on earnings, and if excluded would have raised the EPS by a like amount. Garmin is deferring lifetime maps, connected services and premium traffic over their economic lives. Net deferrals were 19 cents a share in the last quarter. Revenue Revenue of $837.7 million was up 21.0% sequentially (appears to be weaker than normal seasonality). Garmin’s revenue was down 20.9% year over year, the second straight quarter of double-digit decline. Volumes grew sequentially, but declined from last year, while blended average selling prices (“ASPs”) declined both sequentially and year over year.  Specifically, units jumped 58.8% from the previous quarter and dropped 8.6% from last year. This was ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/26/grmn-garmin-quarterly-earnings-misses-consensus/67575/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Agilent Technologies Quarterly Report Tops Expectations &#8211; Lifts 2011 Outlook</title>
		<link>http://www.stockbloghub.com/2011/02/17/a-agilent-technologies-quarterly-report-tops-expectations-lifts-2011-outlook/67119</link>
		<comments>http://www.stockbloghub.com/2011/02/17/a-agilent-technologies-quarterly-report-tops-expectations-lifts-2011-outlook/67119#comments</comments>
		<pubDate>Thu, 17 Feb 2011 23:58:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[NATI]]></category>
		<category><![CDATA[National Instruments Corporation]]></category>
		<category><![CDATA[TER]]></category>
		<category><![CDATA[Teradyne Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67119</guid>
		<description><![CDATA[Agilent Technologies’ (A) first quarter earnings beat the Zacks Consensus by 3 cents, or 5.3%. Revenue growth, expansion in Electronic Measurement segment margins, a lower interest expense and a lower tax rate helped drive results in the last quarter. Revenue Agilent’s revenue was down 3.3% sequentially (normal seasonality) and up 25.6% year over year. Excluding the impact of Varian, Agilent’s revenues were down 3.6% sequentially and up 25.2% from last year, more or less in line with management’s expectations. Currency had a slight positive impact on Agilent’s Life Sciences and Chemical Analysis comparisons and was slightly negative to Electronic Measurement comparisons (when compared with year-ago results). The overall impact of currency on Agilent’s year-over-year comparisons was neutral. Agilent stated that logistics issues caused Varian-based revenue to fall $30 million below ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/17/a-agilent-technologies-quarterly-report-tops-expectations-lifts-2011-outlook/67119/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Company News for February 15, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/02/15/a-company-news-for-february-15-2011-corporate-summary/66978</link>
		<comments>http://www.stockbloghub.com/2011/02/15/a-company-news-for-february-15-2011-corporate-summary/66978#comments</comments>
		<pubDate>Tue, 15 Feb 2011 22:42:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[AAWW]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[Atlas Air Worldwide Holdings Inc]]></category>
		<category><![CDATA[AXT Inc]]></category>
		<category><![CDATA[AXTI]]></category>
		<category><![CDATA[Clorox Corporation]]></category>
		<category><![CDATA[CLX]]></category>
		<category><![CDATA[GMCR]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[Green Mountain Coffee Roasters Inc]]></category>
		<category><![CDATA[MAR]]></category>
		<category><![CDATA[Marriott International Inc.]]></category>
		<category><![CDATA[Netflix Inc.]]></category>
		<category><![CDATA[NFLX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=66978</guid>
		<description><![CDATA[• According to Nielson, Netflix (NASDAQ:NFLX) became a top-ten video service based on total number of streams and unique visitors • Motorola Mobility Holdings (NYSE:MMI) reported it will buy a small company which develops software that boosts the security of mobile devices using Google’s (NASDAQ:GOOG) Android operating system • Agilent Technologies (NYSE:A) reported Q1 EPS of $0.60, topping the Zacks Consensus Estimate of $0.57 per share. Revenues rose 25% year-over-year to $1.52 billion, lower than the Zacks Consensus Estimate of $1.549 billion • Marriott International (NYSE:MAR) announced Q4 EPS of $0.39, above the Zacks Consensus Estimate of $0.36 per share. Revenues for the quarter rose 5.9% to $3.60 billion, topping the Zacks Consensus Estimate of $2.78 billion • Green Mountain Coffee Roaster Inc. (NASDAQ:GMCR) shares rose 6.7% amid reports of possible partnership negotiations with Starbucks ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/15/a-company-news-for-february-15-2011-corporate-summary/66978/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BEC) Company News For December 10, 2010 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2010/12/10/bec-company-news-for-december-10-2010-corporate-summary/61885</link>
		<comments>http://www.stockbloghub.com/2010/12/10/bec-company-news-for-december-10-2010-corporate-summary/61885#comments</comments>
		<pubDate>Fri, 10 Dec 2010 20:13:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[BEC]]></category>
		<category><![CDATA[Beckman Coulter Inc]]></category>
		<category><![CDATA[Capital One Financial Corporation]]></category>
		<category><![CDATA[COF]]></category>
		<category><![CDATA[Community Health Systems]]></category>
		<category><![CDATA[CYH]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[IFF]]></category>
		<category><![CDATA[International Flavors & Fragrances Inc]]></category>
		<category><![CDATA[National Semiconductor Corporation]]></category>
		<category><![CDATA[NSM]]></category>
		<category><![CDATA[Occidental Petroleum Corporation]]></category>
		<category><![CDATA[OXY]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[Tenet Healthcare Corporation]]></category>
		<category><![CDATA[THC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=61885</guid>
		<description><![CDATA[• China&#8217;s Petrochemical agreed to purchase Occidental Petroleum&#8217;s (NYSE:OXY) oil and gas holding in Argentina for $2.45 billion • Community Health (NYSE:CYH) made an offer for Tenet (NYSE:THC) for $3.3 billion, or $6 per share, which the firm declined • Beckman Coulter (NYSE:BEC) is examining prospects for selling itself for about $5 billion • National Semiconductor (NYSE:NSM) posted better-than-estimated fiscal third quarter earnings of $0.34, beating Zacks Consensus Estimate of $0.32, on revenues of $390 million • Goldman Sachs (NYSE:GS) upgraded Procter &#38; Gamble (NYSE:PG) to &#8220;buy,&#8221; with a target price of $75 • RBC initiated coverage of International Flavors &#38; Fragrances (NYSE:IFF) at &#8220;outperform,&#8221; with a target price of $68 • FBR upgraded Capital One (NYSE:COF) to &#8220;outperform&#8221; from &#8220;market perform,&#8221; raising the price target from $45 to $53 BECKMAN COULTER (BEC): Free Stock Analysis Report ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/10/bec-company-news-for-december-10-2010-corporate-summary/61885/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FLIR) FLIR Systems Beats Quarterly Earnings Estimates</title>
		<link>http://www.stockbloghub.com/2010/11/17/flir-flir-systems-beats-quarterly-earnings-estimates/56084</link>
		<comments>http://www.stockbloghub.com/2010/11/17/flir-flir-systems-beats-quarterly-earnings-estimates/56084#comments</comments>
		<pubDate>Thu, 18 Nov 2010 04:44:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[FLIR]]></category>
		<category><![CDATA[FLIR Systems Inc]]></category>
		<category><![CDATA[L-3 Communications Holdings Inc]]></category>
		<category><![CDATA[LLL]]></category>
		<category><![CDATA[LMT]]></category>
		<category><![CDATA[Lockheed Martin Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=56084</guid>
		<description><![CDATA[FLIR Systems Inc. (FLIR) released its second quarter fiscal 2011 earnings results before the market opened today, reporting earnings from continuing operations of 39 cents, beating the Zacks Consensus Estimate of 38 cents. The company continues to deliver a strong operating performance. Revenue Total revenue in the quarter increased by 16% year over year to $332.5 million, below the Zacks Consensus Estimate of $348 million. The company’s revenue increased in all the segments, except for the Government Systems division, which recorded a flat year-over-year revenue of $163.2 million. However, backlog in the division increased by $10 million to $386 million, despite an unclear political environment. The division received strong U.S. government orders. Revenues in the Commercial Systems division, excluding Raymarine, amounted to $132.4 million, an increase of 8%. Revenue from ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/17/flir-flir-systems-beats-quarterly-earnings-estimates/56084/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Agilent Technologies Reports Solid Fourth Quarter &#8211; Raises Guidance</title>
		<link>http://www.stockbloghub.com/2010/11/15/a-agilent-technologies-reports-solid-fourth-quarter-raises-guidance/59431</link>
		<comments>http://www.stockbloghub.com/2010/11/15/a-agilent-technologies-reports-solid-fourth-quarter-raises-guidance/59431#comments</comments>
		<pubDate>Tue, 16 Nov 2010 04:58:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[AME]]></category>
		<category><![CDATA[Ametek Inc.]]></category>
		<category><![CDATA[CGNX]]></category>
		<category><![CDATA[Cognex Corporation]]></category>
		<category><![CDATA[ITRI]]></category>
		<category><![CDATA[Itron Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=59431</guid>
		<description><![CDATA[Agilent Technologies’ (A) fourth quarter earnings beat the Zacks Consensus by 5 cents, or 8.3%. Revenue growth and margin expansion helped drive results in the last quarter. While the gross margin declined sequentially after 5 quarters of increase, Agilent saw both operating and net margins continuing to expand. Revenue Agilent’s revenue grew 14.5% sequentially and 35.7% year over year. Excluding the impact of Varian, Agilent’s revenues were up 27.3% sequentially and 35.0% from last year, much better than management’s expectations of a 16-19% year-over-year increase excluding Varian. While sequential growth was evenly balanced across geographies Incorporatedrease from the year-ago quarter was varied. Asia witnessed the strongest growth at 39.5%, followed by Europe, which grew 35.7% and then the Americas, which grew 32.2%. Agilent’s strong growth in Asia was fueled by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/15/a-agilent-technologies-reports-solid-fourth-quarter-raises-guidance/59431/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Stock Market News for November 12, 2010 &#8211; Market News</title>
		<link>http://www.stockbloghub.com/2010/11/12/a-stock-market-news-for-november-12-2010-market-news/59069</link>
		<comments>http://www.stockbloghub.com/2010/11/12/a-stock-market-news-for-november-12-2010-market-news/59069#comments</comments>
		<pubDate>Fri, 12 Nov 2010 19:33:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[BA]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Boeing Company]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Cisco Systems]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[CSCO]]></category>
		<category><![CDATA[DHI]]></category>
		<category><![CDATA[DIS]]></category>
		<category><![CDATA[DR Horton Inc.]]></category>
		<category><![CDATA[Hewlett-Packard Company]]></category>
		<category><![CDATA[HPQ]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[International Business Machines]]></category>
		<category><![CDATA[J. C. Penney Company]]></category>
		<category><![CDATA[JCP]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[Walt Disney Company]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=59069</guid>
		<description><![CDATA[Sharp differences among global leaders over trade policies and a flaring currency dispute that was keeping investors on toes lost some significance on Thursday as Cisco System’s disappointing outlook surprised the market and sent stocks lower. The Dow average plunged more than 126 points before regaining some lost ground. The blue-chip average closed with a drop of 74 points, or 0.7%, to 11283.10. Cisco (NASDAQ:CSCO) was the average’s leading decliner, dropping more than 16%. The plunge shaved $24 billion off the technology bellwether’s market capitalization. The broader S&#38;P 500 index fell slightly more than 5 points, or 0.4%, to 1213.54 and the technology-focused Nasdaq Composite index fell 23 points, or 0.9%, to 2555.52. On the New York Stock Exchange, two stocks fell in price for every one that advanced. Less ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/12/a-stock-market-news-for-november-12-2010-market-news/59069/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAT) Waters Corporation Earnings Slightly Below The Street</title>
		<link>http://www.stockbloghub.com/2010/11/03/wat-waters-corporation-earnings-slightly-below-the-street/56703</link>
		<comments>http://www.stockbloghub.com/2010/11/03/wat-waters-corporation-earnings-slightly-below-the-street/56703#comments</comments>
		<pubDate>Wed, 03 Nov 2010 18:20:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[WAT]]></category>
		<category><![CDATA[Waters Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=56703</guid>
		<description><![CDATA[Waters Corp. (WAT) released its third quarter earnings before the market opened today, reporting earnings from continuing operation of 96 cents, slightly below the Zacks Consensus Estimate of 97 cents.  Earnings in the quarter increased by 21.5% from 79 cents in the third quarter of 2009. Revenue On the top line, WAT outperformed the Zacks Consensus Estimate of $397 million by merely $4 million, reporting total revenue of $401 million.  Total revenue during the quarter increased by 7% year over year as the company delivered solid performance in its pharmaceutical and chemical end markets. Foreign currency translation negatively impacted the company’s sales by 2%. Sales in the quarter were primarily driven by delivery of new instrument systems Incorporatedluding ACQUITY H-Class UPLC and increased demand for the research-focused mass spectrometry products. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/03/wat-waters-corporation-earnings-slightly-below-the-street/56703/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAT) Waters  Corporation Third Quarter 2010 Earnings Preview</title>
		<link>http://www.stockbloghub.com/2010/10/25/wat-waters-corporation-third-quarter-2010-earnings-preview/56397</link>
		<comments>http://www.stockbloghub.com/2010/10/25/wat-waters-corporation-third-quarter-2010-earnings-preview/56397#comments</comments>
		<pubDate>Tue, 26 Oct 2010 04:48:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[WAT]]></category>
		<category><![CDATA[Waters Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=56397</guid>
		<description><![CDATA[Waters Corp. (WAT) is slated to report its third quarter 2010 earnings on October 26, 2010 before the opening bell. The current Zacks Consensus Estimate for the third quarter is 97 cents per share, representing a year-over-year growth of 4.3%. Waters has surpassed earnings estimates consistently in the last four quarters with a trailing four-quarter average surprise of 3.55%. Second Quarter Recap Waters Corp.’s second quarter 2010 per share from continuing operations was 90 cents, an increase of 25% from 72 cents in the second quarter of 2009. On the top line, Waters outperformed the Zacks Consensus Estimate by merely $3 million, reporting total revenue of $391 million.  Total revenue during the quarter increased by 8% year over year as the company experienced strong demand for its products in key ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/25/wat-waters-corporation-third-quarter-2010-earnings-preview/56397/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ITRI) Itron Analyst Maintains Shar Rating at Neutral</title>
		<link>http://www.stockbloghub.com/2010/10/17/itri-itron-analyst-maintains-shar-rating-at-neutral/55328</link>
		<comments>http://www.stockbloghub.com/2010/10/17/itri-itron-analyst-maintains-shar-rating-at-neutral/55328#comments</comments>
		<pubDate>Mon, 18 Oct 2010 03:18:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Badger Meter Inc]]></category>
		<category><![CDATA[BMI]]></category>
		<category><![CDATA[CBE]]></category>
		<category><![CDATA[Cooper Industries Limited]]></category>
		<category><![CDATA[Emerson Electric Company]]></category>
		<category><![CDATA[EMR]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[ITRI]]></category>
		<category><![CDATA[Itron Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=55328</guid>
		<description><![CDATA[We maintain our Neutral recommendation for Itron, Inc. (ITRI) which means the stock should perform mostly in line with the broader market. The AMI (advanced metering infrastructure) and AMR (automated meter reading) markets exhibit the maximum growth potential. Some ongoing projects with giant water and waste producers will enhance its brand reorganization and expand its hold in the market. However, competitive threats from bigger companies, exposure to the European market and long sales cycles may have adverse effects on its business. We believe the technology-based AMI and AMR markets have huge growth prospects in the years ahead, providing Itron with ample scope for growth and expansion. AMR and AMI meters are capable of managing, measuring, collecting, analyzing and transferring large data sets using radio frequency or mobile or network technologies ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/17/itri-itron-analyst-maintains-shar-rating-at-neutral/55328/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Company News for October 7, 2010 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2010/10/07/a-company-news-for-october-7-2010-corporate-summary/54278</link>
		<comments>http://www.stockbloghub.com/2010/10/07/a-company-news-for-october-7-2010-corporate-summary/54278#comments</comments>
		<pubDate>Thu, 07 Oct 2010 23:05:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[CBS]]></category>
		<category><![CDATA[CBS Corporation]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[DB]]></category>
		<category><![CDATA[Deutsche Bank AG]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[Genuine Parts Company]]></category>
		<category><![CDATA[GPC]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[MAR]]></category>
		<category><![CDATA[Marriott International Inc.]]></category>
		<category><![CDATA[PEP]]></category>
		<category><![CDATA[Pepsico]]></category>
		<category><![CDATA[PRU]]></category>
		<category><![CDATA[Prudential Financial Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54278</guid>
		<description><![CDATA[• PepsiCo (NYSE:PEP) reported third-quarter earnings of $1.22, in-line with expectations, on a 40% revenue jump to $15.5 billion, above projections of $15.4 billion. The firm also lowered 2010 guidance to 10-11% growth • Marriott (NYSE:MAR) noted third quarter earnings missed by a penny, coming in at 22 cents on revenues of $2.65 billion, up 7.2% YoY, and inline with estimates of $2.66 billion • Deutsche Bank (NYSE:DB) started coverage of Agilent Technologies (NYSE:A) with a &#8220;buy&#8221; rating and a $41.50 price target • Nomura initiated coverage of Citigroup (NYSE:C) and JP Morgan (NYSE:JPM) with &#8220;buy&#8221; ratings • Deutsche Bank (NYSE:DB) maintained a &#8220;hold&#8221; rating on General Electric (NYSE:GE) but lifted the price target to $20 from $19 • Needham kept a &#8220;buy&#8221; on CBS (NYSE:CBS), with a price target of $19 • FBR maintained an &#8220;outperform/top ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/07/a-company-news-for-october-7-2010-corporate-summary/54278/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BEC) Beckman Coulter Incorporated &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2010/09/28/bec-beckman-coulter-incorporated-bear-of-the-day/52858</link>
		<comments>http://www.stockbloghub.com/2010/09/28/bec-beckman-coulter-incorporated-bear-of-the-day/52858#comments</comments>
		<pubDate>Tue, 28 Sep 2010 14:09:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[BEC]]></category>
		<category><![CDATA[Beckman Coulter Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=52858</guid>
		<description><![CDATA[Currently, the most important issue facing Beckman Coulter (BEC) is the warning letter related to its troponin test kits. This overhang has cut revenues in addition to impacting client additions based on which the outlook has been lowered. Although Beckman is working with the FDA to conduct the required trial, clearance is not expected before mid-2011. Additional factors affecting the company are lower demand for life science products and delay in cellular product launch. Given these inhibiting factors, we prefer to avoid this stock until issues are resolved. Accordingly, we initiate coverage on Beckman with an Underperform rating. BECKMAN COULTER (BEC): Free Stock Analysis Report Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/28/bec-beckman-coulter-incorporated-bear-of-the-day/52858/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CRA) Celera Corpoation and Abbott Laboratories Sign Deal</title>
		<link>http://www.stockbloghub.com/2010/09/23/cra-celera-corpoation-and-abbott-laboratories-sign-deal/52551</link>
		<comments>http://www.stockbloghub.com/2010/09/23/cra-celera-corpoation-and-abbott-laboratories-sign-deal/52551#comments</comments>
		<pubDate>Thu, 23 Sep 2010 15:11:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Celera Corporation]]></category>
		<category><![CDATA[CRA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=52551</guid>
		<description><![CDATA[Recently, Celera Corporation (CRA) has signed a four-year distribution agreement with Abbott Laboratories (ABT) to market Celera’s KIF6 diagnostic test in Abbott’s m2000 instrument. The KIF6 test is aimed at identifying an individual’s risk of coronary heart disease (CHD) and response to statin therapy. Earlier, in June 2010, Celera received CE Mark approval for its real-time PCR (polymerase chain reaction) test to detect a variant in the KIF6 gene. While Celera will manufacture the KIF6 test kits, Abbott will be responsible for its distribution in Europe and other regions recognizing the CE Mark. However, financial terms of the deal were not disclosed. We believe immense potential lies in the detection of CHD as it has been observed that a variant of the KIF6 gene is related to about 55% increased ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/23/cra-celera-corpoation-and-abbott-laboratories-sign-deal/52551/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CRA) CRA International Incorporated &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2010/08/22/cra-cra-international-incorporated-bear-of-the-day/48964</link>
		<comments>http://www.stockbloghub.com/2010/08/22/cra-cra-international-incorporated-bear-of-the-day/48964#comments</comments>
		<pubDate>Mon, 23 Aug 2010 06:49:22 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Celera Corporation]]></category>
		<category><![CDATA[CRA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=48964</guid>
		<description><![CDATA[CRA International&#8217;s (CRA) second-quarter earnings were modestly ahead of the Zacks Consensus Estimate primarily owing to the uptick in utilization rate backed by successful restructuring actions. Although litigation and management consulting related areas were reasonably active, clients cautious aggregate spending and a decline in organic revenue are expected to limit the company s growth. Overall, near-term visibility remains unclear, given the current volatile market trends. Despite showing some improvement, litigation trend remains sluggish. Finally, despite the recent pick-up in activity, the Middle East business remains uncertain. Going forward, we remain skeptical about the sustainability of the growth momentum seen in the second quarter. Hence, we downgrade the stock from Neutral to Underperform. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/22/cra-cra-international-incorporated-bear-of-the-day/48964/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CRA) Fannie Mae, Freddie Mac and the Federal Housing Authority Problems</title>
		<link>http://www.stockbloghub.com/2010/08/11/cra-fannie-mae-freddie-mac-and-the-federal-housing-authority-problems/47418</link>
		<comments>http://www.stockbloghub.com/2010/08/11/cra-fannie-mae-freddie-mac-and-the-federal-housing-authority-problems/47418#comments</comments>
		<pubDate>Wed, 11 Aug 2010 14:56:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Celera Corporation]]></category>
		<category><![CDATA[CRA]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[Housing]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=47418</guid>
		<description><![CDATA[The ultimate indication of a mortgage that has gone bad is when the lender forecloses and ends up owning the property. The graph below (from http://www.calculatedriskblog.com/) shows the number of properties that are in &#8220;Real Estate Owned&#8221; status (REO) by Fannie Mae (FNMA), Freddie Mac, the Federal Housing Authority and owned by the owners of the private-label mortgage-backed securities that were created by the likes of Merrill Lynch (now part of Bank of America, BAC) and its now defunct brethren Bear Stearns (now owned by J.P. Morgan, JPM) and Lehman Brothers. The graph speaks volumes about the housing bubble and its aftermath. The first thing to note by way of background is that the private-label paper creation pretty much came to an end in 2007 when the housing market first started to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/11/cra-fannie-mae-freddie-mac-and-the-federal-housing-authority-problems/47418/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FLIR) FLIR Systems&#8217; Second Quarter 2010 Earnings Beat &#8211; Raises Revenue Outlook</title>
		<link>http://www.stockbloghub.com/2010/07/23/flir-flir-systems-second-quarter-2010-earnings-beat-raises-revenue-outlook/44459</link>
		<comments>http://www.stockbloghub.com/2010/07/23/flir-flir-systems-second-quarter-2010-earnings-beat-raises-revenue-outlook/44459#comments</comments>
		<pubDate>Fri, 23 Jul 2010 20:10:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[FLIR]]></category>
		<category><![CDATA[FLIR Systems Inc]]></category>
		<category><![CDATA[L-3 Communications Holdings Inc]]></category>
		<category><![CDATA[LLL]]></category>
		<category><![CDATA[LMT]]></category>
		<category><![CDATA[Lockheed Martin Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=44459</guid>
		<description><![CDATA[FLIR Systems Inc. (FLIR) reported a 5.7% increase in its earnings of 37 cents per share for the second quarter of 2010, beating the Zacks Consensus Estimate of 35 cents per share. Revenue Total revenue for the quarter increased 19% year over year to $331.1 million. About $27 million of revenue was derived from Raymarine acquisition, excluding which total revenue increased 9%. FLIR Systems experienced revenue growth in all its segments. The company’s Commercial Systems division recorded highest year-over-year revenue growth of 16% to $136.0 million followed by a growth of 7% at the Thermography division to $71.4 million. Government Systems division revenues increased 5% to $167.9 million during the quarter. Backlog At the end of the quarter, total backlog of the company, which will expire in next twelve months, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/23/flir-flir-systems-second-quarter-2010-earnings-beat-raises-revenue-outlook/44459/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Agilent Technologies Beats Quarterly Earnings by a Penny</title>
		<link>http://www.stockbloghub.com/2010/05/18/a-agilent-technologies-beats-quarterly-earnings-by-a-penny/37521</link>
		<comments>http://www.stockbloghub.com/2010/05/18/a-agilent-technologies-beats-quarterly-earnings-by-a-penny/37521#comments</comments>
		<pubDate>Tue, 18 May 2010 15:37:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=37521</guid>
		<description><![CDATA[Agilent Technologies Inc. (A) beat the second quarter Zacks Consensus earnings per share by a penny, or 2.4%. Revenue of $1.27 billion beat by 2.5%. Shares were buoyant during the day, but dropped off 2.02% after-hours. Agilent saw another quarter of expansion in gross, operating and net margins. However, investors probably expected stronger earnings, since the positive surprise percentage averaged at around 20.7% in the preceding four quarters. Revenue Agilent’s revenue grew 4.8% sequentially and 16.5% year over year. The growth witnessed in the reported quarter was comparable to pre-recession rates. Revenue was fueled by improving demand across all geographies, with Asia witnessing the strongest growth at 26% (24% when adjusted for currency), followed by the Americas, which grew 13% (11% when adjusted for currency) and then Europe, which grew ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/18/a-agilent-technologies-beats-quarterly-earnings-by-a-penny/37521/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MIL) Millipore Quarterly Earnings Report Ahead of Expectations</title>
		<link>http://www.stockbloghub.com/2010/05/07/mil-millipore-quarterly-earnings-report-ahead-of-expectations/36525</link>
		<comments>http://www.stockbloghub.com/2010/05/07/mil-millipore-quarterly-earnings-report-ahead-of-expectations/36525#comments</comments>
		<pubDate>Fri, 07 May 2010 16:28:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[MIL]]></category>
		<category><![CDATA[Millipore Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=36525</guid>
		<description><![CDATA[Millipore Corp. (MIL) reported first-quarter earnings per share of $1.21, well above the Zacks Consensus Estimate of $1.09 and the year-ago earnings of $1.06. Revenues for the first quarter grew 14% to $463 million. Excluding a 5% benefit from changes in foreign currency, Millipore generated organic revenue growth of 9%. While the Bioprocess division recorded a growth of 12% with sales coming in at $258.3 million, the Bioscience division grew 15% to $204.7 million. New product sales and increased demand from biotech customers helped the Bioprocess division generate organic growth of 13% during the quarter. A major part of the growth was driven by biotech customers in North America and Asia. Demand should remain strong with large pharma companies increasing their investment in biotech drugs. We believe Millipore will gain ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/07/mil-millipore-quarterly-earnings-report-ahead-of-expectations/36525/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GRMN) Garmin Limited&#8217;s Quarterly Earnings Report Misses &#8211; Bids for Raymarine</title>
		<link>http://www.stockbloghub.com/2010/05/06/grmn-garmin-limiteds-quarterly-earnings-report-misses-bids-for-raymarine/36491</link>
		<comments>http://www.stockbloghub.com/2010/05/06/grmn-garmin-limiteds-quarterly-earnings-report-misses-bids-for-raymarine/36491#comments</comments>
		<pubDate>Thu, 06 May 2010 23:24:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Garmin Limited]]></category>
		<category><![CDATA[GRMN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=36491</guid>
		<description><![CDATA[Garmin Ltd.’s (GRMN) first quarter earnings excluding the impact of foreign exchange missed the Zacks Consensus Estimate by 4 cents in a seasonally weak quarter for the company. Earnings were up 52% from the year-ago quarter. Revenue Revenue of $431 million was down 59.3% sequentially and 1.3% year over year. The decline from the year-ago quarter was related to a 1.3% decline in the blended ASP (average sale price), as volumes stayed essentially flat. The sequential decline was mainly on account of the every strong fourth quarter, which typically generates over 30% of total revenue for the year. The revenue decline was more pronounced in North America and Europe, which are the regions that experience particular holiday-driven strength in the Dec quarter. Moreover, PND adoption in Asia remains encouraging. North ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/06/grmn-garmin-limiteds-quarterly-earnings-report-misses-bids-for-raymarine/36491/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TRMB) Trimble Navigation Report Beats Expectations &#8211; Outlook Cautious</title>
		<link>http://www.stockbloghub.com/2010/05/03/trmb-trimble-navigation-report-beats-expectations-outlook-cautious/35900</link>
		<comments>http://www.stockbloghub.com/2010/05/03/trmb-trimble-navigation-report-beats-expectations-outlook-cautious/35900#comments</comments>
		<pubDate>Mon, 03 May 2010 21:56:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[General Mills Inc.]]></category>
		<category><![CDATA[GIS]]></category>
		<category><![CDATA[Trimble Navigation Limited]]></category>
		<category><![CDATA[TRMB]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=35900</guid>
		<description><![CDATA[Trimble Navigation’s (TRMB) first quarter earnings exceeded consensus estimates by 3 cents. While GAAP earnings also exceeded management’s expectations, non-GAAP earnings were at the high end of management’s guided range. Seasonality typically causes huge sequential fluctuations in both revenue and margins. As a result, management generally compares results on a year-over-year basis. We have included sequential comparisons, where required. Revenue Revenue of $319.0 million was up 14.9% sequentially and 10.4% year over year, exceeding the high end of the guided range of $308-313 million (up 11-13% sequentially). Trimble’s recovery remains slow and uneven, with E&#38;C, the largest segment continuing to be impacted by the recession and technology spending in other areas also remaining limited. Revenue by Segment E&#38;C unit revenue of $157.6 million was up 2.1% sequentially and 23.5% year over ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/03/trmb-trimble-navigation-report-beats-expectations-outlook-cautious/35900/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TMO) Thermo Fisher Scientific Announces Aquisition of Proxeon</title>
		<link>http://www.stockbloghub.com/2010/04/19/tmo-thermo-fisher-scientific-announces-aquisition-of-proxeon/34313</link>
		<comments>http://www.stockbloghub.com/2010/04/19/tmo-thermo-fisher-scientific-announces-aquisition-of-proxeon/34313#comments</comments>
		<pubDate>Mon, 19 Apr 2010 21:48:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=34313</guid>
		<description><![CDATA[Thermo Fisher Scientific Inc. (TMO) announced that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis. Financial terms of the transaction have not been disclosed. Thermo Fisher plans to integrate Proxeon into its Analytical Technologies Segment. The company does not expect the acquisition to have a material impact on its fiscal 2010 results. Proxeon A/S provides a simplified proteomics workflow Incorporatedluding nanoflow liquid chromatography systems, columns, ion sources and bioinformatics software. This allows a robust high-sensitivity liquid chromatography/mass spectrometry (LC/MS) analysis in complex proteomics applications. Proxeon generated sales of roughly $10 million in fiscal 2009. Proxeon’s nanoflow liquid chromatography system, EASY-nLC, is simple and easy to use. The system supports an intuitive graphical user interface and has a remote diagnostics capability. In addition, the compact system ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/19/tmo-thermo-fisher-scientific-announces-aquisition-of-proxeon/34313/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TMO) Thermo Fisher Scientific Analyst Remains Neutral</title>
		<link>http://www.stockbloghub.com/2010/04/14/tmo-thermo-fisher-scientific-analyst-remains-neutral/33724</link>
		<comments>http://www.stockbloghub.com/2010/04/14/tmo-thermo-fisher-scientific-analyst-remains-neutral/33724#comments</comments>
		<pubDate>Wed, 14 Apr 2010 21:35:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=33724</guid>
		<description><![CDATA[We have retained our ‘Neutral’ rating on Thermo Fisher Scientific, Inc. (TMO) with a target price of $55 based on a P/E of 16.2 and our fiscal 2010 EPS estimate of $3.39. The company’s results for the fourth quarter and fiscal 2009 were mixed. Thermo Fisher Scientific reported fourth-quarter earnings per share of 91 cents, surpassing the Zacks Consensus Estimate of 88 cents and the year-ago earnings of 87 cents. For fiscal 2009, earnings per share were $3.05, compared to the Zacks Consensus Estimate of $3.02 and $3.13, a year ago. In the fourth quarter, total revenues increased 7% year over year to a record $2.84 billion. Growth was fueled by acquisitions and a favorable foreign currency translation. Analytical Technologies revenues increased 5% year over year to $1.19 billion. Laboratory ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/14/tmo-thermo-fisher-scientific-analyst-remains-neutral/33724/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Agilant Technologies &#8211; Shares Trade at a Discount to Industry Average</title>
		<link>http://www.stockbloghub.com/2010/04/13/a-agilant-technologies-shares-trade-at-a-discount-to-industry-average/33533</link>
		<comments>http://www.stockbloghub.com/2010/04/13/a-agilant-technologies-shares-trade-at-a-discount-to-industry-average/33533#comments</comments>
		<pubDate>Tue, 13 Apr 2010 14:49:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=33533</guid>
		<description><![CDATA[Agilant Technologies (A) continues to pressure its 52-week high on rising estimates, a compelling valuation relative to its peers and a bullish next-year estimate. Company Description Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions to a number of industries in the United States and internationally. The company was founded in 1999 and has a market cap of $11.92 billion. First-Quarter Results Agilant reported strong Q1 results on February 12 that helped shares kick off the current rally. Revenue for the period was up 4% from last year to $1.21 billion. Earnings came in at 38 cents, 19% ahead of the Zacks Consensus Estimate. The company has surprised in each of the last three quarters by an average of 30%. Agilant noted that it saw strong growth in its Chemical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/13/a-agilant-technologies-shares-trade-at-a-discount-to-industry-average/33533/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BMI) Badger Meter Incorporated &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2010/04/05/bmi-badger-meter-incorporated-bear-of-the-day/32717</link>
		<comments>http://www.stockbloghub.com/2010/04/05/bmi-badger-meter-incorporated-bear-of-the-day/32717#comments</comments>
		<pubDate>Mon, 05 Apr 2010 17:59:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Badger Meter Inc]]></category>
		<category><![CDATA[BMI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32717</guid>
		<description><![CDATA[We are downgrading our recommendation on Badger Meter Inc. (BMI) to Underperform from Neutral as we anticipate it to perform well below the broader market. Badger Meter&#8217;s vulnerability to macroeconomic conditions as well as delayed customer orders is adversely affecting its top-line growth. The company recorded a 16.6% year-over-year reduction in total revenues during the fourth quarter of 2009. Moreover, intense competition from other well-established players, heavy dependence on key suppliers and exposure to foreign currency fluctuations undermine the company&#8217;s future growth prospects and profitability. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/05/bmi-badger-meter-incorporated-bear-of-the-day/32717/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FLIR) Flir Systems Earns $13.5 Million Order</title>
		<link>http://www.stockbloghub.com/2010/04/01/flir-flir-systems-earns-13-5-million-order/32642</link>
		<comments>http://www.stockbloghub.com/2010/04/01/flir-flir-systems-earns-13-5-million-order/32642#comments</comments>
		<pubDate>Thu, 01 Apr 2010 21:39:22 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[FLIR]]></category>
		<category><![CDATA[FLIR Systems Inc]]></category>
		<category><![CDATA[L-3 Communications Holdings Inc]]></category>
		<category><![CDATA[LLL]]></category>
		<category><![CDATA[LMT]]></category>
		<category><![CDATA[Lockheed Martin Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32642</guid>
		<description><![CDATA[FLIR Systems Inc. (FLIR) announced that it has obtained a $13.5 million order from Naval Surface Warfare Center (NSWC), Crane Division for its BRITE Star® II multi-sensor target designation systems. The units delivered under this order will be used by the U.S. Marine Corps and U.S. Navy for various missions. The company produces invisible infrared cameras and night vision technology, which is used at all American airports. FLIR&#8217;s equipment is also used to protect nuclear facilities and U.S. bases in Afghanistan. Bullishness on FLIR is attributed to rising orders and what appears as an attractive valuation. FLIR is a pure play on thermal imaging and infrared technology, an area with lots of growth potential. The company has developed extensive competencies in the design and integration of numerous capabilities and payloads. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/01/flir-flir-systems-earns-13-5-million-order/32642/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CGNX) Cognex Corporation &amp; Fuji Machine Manufacturing Resolve Dispute</title>
		<link>http://www.stockbloghub.com/2010/03/29/cgnx-cognex-corporation-fuji-machine-manufacturing-resolve-dispute/31716</link>
		<comments>http://www.stockbloghub.com/2010/03/29/cgnx-cognex-corporation-fuji-machine-manufacturing-resolve-dispute/31716#comments</comments>
		<pubDate>Mon, 29 Mar 2010 21:12:34 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[CGNX]]></category>
		<category><![CDATA[Cognex Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=31716</guid>
		<description><![CDATA[Cognex Corporation (CGNX) announced that it has reached a settlement with Fuji Machine Manufacturing Co., Ltd. and its U.S. subsidiary Fuji America Corporation, relating to the import and sale of equipment using machine vision software. Other terms of the resolution were not disclosed. Cognex&#8217;s dispute with other machine vision companies continues in the United States International Trade Commission and in the District Court of Massachusetts. In May 2009, Cognex had filed a complaint with the United States International Trade Commission (ITC) against MvTec Software GmbH, MvTec LLC, Fuji America, and several other respondents alleging unfair methods of competition and unfair acts in the unlawful import into the United States, sale for import, or sale within the United States after import. Through this filing, Cognex has asked the ITC to investigate ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/29/cgnx-cognex-corporation-fuji-machine-manufacturing-resolve-dispute/31716/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TMO) Thermo Fisher Scientific Expands Agreement with Eli Lilly</title>
		<link>http://www.stockbloghub.com/2010/03/29/tmo-thermo-fisher-scientific-expands-agreement-with-eli-lilly/32177</link>
		<comments>http://www.stockbloghub.com/2010/03/29/tmo-thermo-fisher-scientific-expands-agreement-with-eli-lilly/32177#comments</comments>
		<pubDate>Mon, 29 Mar 2010 20:57:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32177</guid>
		<description><![CDATA[Thermo Fisher Scientific Inc. (TMO) recently expanded its clinical trial materials supply chain relationship agreement with Eli Lilly and Company (LLY). Per the new five-year agreement, Thermo Fisher will take over the responsibility of Lilly’s in-house clinical trial materials manufacturing, packaging and labeling operations at the Lilly Technology Center in Indianapolis. The Fisher Clinical Services segment of Thermo Fisher will handle this transition and expects it to be completed by this summer. Furthermore, the segment will handle the distribution of clinical trial materials for Lilly throughout North America by the end of 2010. The new agreement includes the purchase of Lilly’s clinical trial manufacturing and packaging equipment. This was done to reduce a portion of Lilly’s fixed costs. Eli Lilly has designed a new operating model that speeds the delivery ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/29/tmo-thermo-fisher-scientific-expands-agreement-with-eli-lilly/32177/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TMO) Thermo Fisher Scientific Acquires Finnzymes</title>
		<link>http://www.stockbloghub.com/2010/03/09/tmo-thermo-fisher-scientific-acquires-finnzymes/30161</link>
		<comments>http://www.stockbloghub.com/2010/03/09/tmo-thermo-fisher-scientific-acquires-finnzymes/30161#comments</comments>
		<pubDate>Tue, 09 Mar 2010 23:06:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30161</guid>
		<description><![CDATA[Thermo Fisher Scientific, Inc. (TMO) recently completed the acquisition of Finnzymes. Financial terms of the agreement have not been disclosed. The acquisition is not expected to have any material impact on the company’s financial results in fiscal 2010. Finnzymes is a Finland-based provider of integrated tools for molecular biology analysis Incorporatedluding reagents, instruments, consumables and kits. The company generated revenues of $20 million in fiscal 2009. The Finnzymes acquisition will expand Thermo Fisher’s portfolio of reagents and other consumables for the molecular biology research and diagnostics markets. Finnzymes has expertise in DNA polymerases, which have demonstrated significant increases in the performance of enzymes. This benefits a variety of applications in different fields like genetic testing, basic genomic research, forensics and food testing. Thermo Fisher will add Finnzymes primarily to its ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/09/tmo-thermo-fisher-scientific-acquires-finnzymes/30161/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Agilent Technologies on Road to Recovery</title>
		<link>http://www.stockbloghub.com/2010/03/08/a-agilent-technologies-on-road-to-recovery/30071</link>
		<comments>http://www.stockbloghub.com/2010/03/08/a-agilent-technologies-on-road-to-recovery/30071#comments</comments>
		<pubDate>Tue, 09 Mar 2010 00:00:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30071</guid>
		<description><![CDATA[Following stellar results in the fiscal first quarter ended January 2010, Agilent Technologies’ (A) CFO, Adrian Dillon, has left the company. However, despite Dillon’s long stint at Agilent, share prices did not reflect concern due to his departure. This is mainly because the company’s end markets are seeing strong recovery that Agilent is well positioned to take advantage of. Stronger Markets Revenue was ahead of the Zacks Consensus in the last quarter, with North America stabilizing, Europe benefiting from currency gains and Asia continuing to grow strongly. The company also changed its reporting structure to better reflect the growing prospects in the previously reported Bio-Analytical segment. This segment has now been split into Life Sciences and Chemical Analysis. The rest of the revenue was reported under the Electronic Measurement segment. Food, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/08/a-agilent-technologies-on-road-to-recovery/30071/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CRA) Celera Corporation&#8217;s Revenues Dip</title>
		<link>http://www.stockbloghub.com/2010/03/04/cra-celera-corporations-revenues-dip/29711</link>
		<comments>http://www.stockbloghub.com/2010/03/04/cra-celera-corporations-revenues-dip/29711#comments</comments>
		<pubDate>Thu, 04 Mar 2010 16:52:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Celera Corporation]]></category>
		<category><![CDATA[CRA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29711</guid>
		<description><![CDATA[Celera Corporation (CRA) reported fourth-quarter fiscal 2009 (ended Dec 26, 2009) earnings of 2 cents per share (excluding special items) compared to the Zacks Consensus Estimate of a net loss of 4 cents. The company earned 3 cents (excluding special items) in the year-ago quarter. Net revenues in the reported quarter came in at $40 million as against $47.3 million in the year-ago quarter, down approximately 15.4%. Segment-wise, revenues from lab services fell approximately 25% to $22 million compared to $29.2 million in the year-ago quarter, primarily because of lower reimbursement rates and lower sample volume. Revenues from products climbed 1% year-over-year to $11.3 million. Corporate revenues, which fell 3% year-over-year, accounted for the balance. Research and Development spending in the reported quarter decreased to $6.5 million from $7.6 million ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/04/cra-celera-corporations-revenues-dip/29711/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MIL) Merck KGaA Buys Millipore (Revised)</title>
		<link>http://www.stockbloghub.com/2010/03/03/mil-merck-kgaa-buys-millipore-revised/29494</link>
		<comments>http://www.stockbloghub.com/2010/03/03/mil-merck-kgaa-buys-millipore-revised/29494#comments</comments>
		<pubDate>Wed, 03 Mar 2010 23:35:09 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MIL]]></category>
		<category><![CDATA[Millipore Corporation]]></category>
		<category><![CDATA[MRK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29494</guid>
		<description><![CDATA[Millipore Corporation (MIL), a leading life science company, and Merck KGaA, the Germany-based pharmaceutical and chemicals company, entered into a definitive agreement under which Merck will acquire all outstanding shares of common stock of Millipore for US$107 per share in cash, or a total transaction value Incorporatedluding net debt, of approximately €5.3 billion (US$7.2 billion). MercK KGaA, also called the German Merck or Merck Dermstadt is one of the oldest chemical and pharmaceutical companies in the world. The company lost its foreign assets following the First World War Incorporatedluding its U.S. subsidiary that eventually became Merck &#38; Company (MRK). Since Merck &#38; Company holds the rights to the Merck name in the U.S., Merck KGaA operates here under the name EMD Chemicals (EMD stands for Emanuel Merck, Dermstadt). Merck KGaA ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/03/mil-merck-kgaa-buys-millipore-revised/29494/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TMO) Thermo Fisher Scientific Acquires Ahura</title>
		<link>http://www.stockbloghub.com/2010/03/01/tmo-thermo-fisher-scientific-acquires-ahura/29382</link>
		<comments>http://www.stockbloghub.com/2010/03/01/tmo-thermo-fisher-scientific-acquires-ahura/29382#comments</comments>
		<pubDate>Mon, 01 Mar 2010 23:37:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29382</guid>
		<description><![CDATA[Thermo Fisher Scientific, Inc. (TMO) recently completed the acquisition of Ahura Scientific for $145 million in cash plus the potential for an earn-out payment based on the achievement of certain 2010 financial targets. Thermo Fisher has now decided to integrate Ahura into its Analytical Technologies Segment. Ahura Scientific is a leader in handheld Raman and FT-IR (Fourier-transform infrared) spectroscopy instruments that are used globally in the identification of chemicals for safety, security and pharmaceutical applications. The company generated fiscal 2009 revenues of roughly $45 million. The Ahura acquisition will expand Thermo Fisher’s client base that will cater to the company’s top-line growth. Thermo fisher recently reported fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share was 91 cents, surpassing the Zacks Consensus Estimate of 88 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/01/tmo-thermo-fisher-scientific-acquires-ahura/29382/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

